Mental disorders in children with rheumatic diseases
Научно-практическая ревматологияThe prevalence of concomitant mental disorders in children with rheumatic diseases is notably higher than in the overall population. However, psychiatric comorbidity in pediatric rheumatology remains poorly understood, whereas approaches to mental ...
A. V. Santimov +2 more
doaj +1 more source
Anorexia Nervosa in Juvenile Systemic Lupus Erythematosus (SLE): A Causality Dilemma. [PDF]
Children (Basel), 2023 Grammatikopoulou MG +7 more
europepmc +1 more source
Системні прояви синдрому токсемії та імунологічна реактивність у хворих на системний червоний вовчак [PDF]
, 2003 In work are submitted researches of a state of an immune responsiveness and mechanisms formation of a set of symptoms of a toxemia at the patients with a systemic lupus erythematosus.
Лозіна, Л.Б., Сміян, С.І.
core
Symptomatic Bilateral Sacroiliitis in a Patient with Juvenile Systemic Lupus Erythematosus: A Rare Association. [PDF]
Mediterr J Rheumatol, 2023 Gupta V, Dhanota DS.
europepmc +1 more source
Evaluation of Bone Mineral Density in Juvenile Systemic Lupus Erythematosus. [PDF]
Arch Bone Jt Surg, 2023 Soti Khiabani M +3 more
europepmc +1 more source
Circulating prolactin level in Juvenile Systemic Lupus Erythematosus and its correlation with disease activity: a case control study. [PDF]
Pediatr Rheumatol Online J, 2023 Soliman HM, Fahmy BS, Ali MG, Shafie ES.
europepmc +1 more source
Juvenile Systemic Lupus Erythematosus in Boys [PDF]
Journal of Clinical Case Studies, 2018 Mozolova D, Rovensky J
openaire +1 more source
Analysis of choroidal thickness in juvenile systemic lupus erythematosus and its correlation with laboratory tests. [PDF]
BMC Ophthalmol, 2023 Ru L, Xu J, Lin Z, Cao L, Zhang L.
europepmc +1 more source
Biologic treatments in rheumatoid arthritis and juvenile idiopathic arthritis [PDF]
, 2006 A number of biological approaches to the management of inflammtory arthropathies have been explored. These include the development of IL-1 receptor antagonists and TNF antagonists. Four biological agents are currently marketed in Europe.
Borg, Andrew A.
core
Novel heterozygous TREX1 mutation in a juvenile systemic lupus erythematosus patient with severe cutaneous involvement treated successfully with Jak-inhibitors: a case report. [PDF]
Front Immunol, 2023 Rossano M +8 more
europepmc +1 more source